http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019032411-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9db0897095b87e31d7342ea8a247d6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a71fcbfdadd71a9e5239c12b9d492b6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f16d94b0d9bffa1ab2e0a6aa10c75cbd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-24 |
| filingDate | 2018-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c316d55c49f172de42bc7d322b457c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502847b1b834ec3fae75c706598d7aaa |
| publicationDate | 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019032411-A1 |
| titleOfInvention | COMPOSITIONS AND METHODS FOR INDUCING APOPTOSIS IN ANAEROBIC CELLS AND ASSOCIATED CLINICAL METHODS FOR THE TREATMENT OF CANCER AND PATHOGENIC INFECTIONS |
| abstract | The present invention provides potent anti-cancer methods as well as anti-cancer compositions using novel glycome compounds exemplified by glyco-benzaldehydes that disrupt anaerobic respiration and trigger apoptosis in cancer cells. Also provided are compositions and methods useful for treating viral and microbial infections, and for strengthening weakened immune systems, including disrupting alpha-N-acetylgalactosaminidase (nagalase) function and decreasing circulating nagalase levels in the body. the blood. According to certain methods and compositions provided by the present invention for anti-cancer treatment and immune enhancement, glyco-benzaldehyde compounds, such as plant-derived helicidum glyco-benzaldehyde, alone or in combination, are used for Powerfully destroy circulating tumors and cancer cells, and significantly extend the survival of cancer patients, including patients with Stage III and Stage IV resistant cancer. |
| priorityDate | 2017-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 802.